Concepedia

One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation

Uday M. Khosla, Jill Martin, Geraldine M. Baker, Timothy Schroeder, M. Roy First

Transplantation Proceedings · 1999 · 14 citations · 3 references

Concepts

MedicineNephrologyPharmacotherapyKidney TransplantationRenal PharmacotherapyTransplant PharmacotherapyDeceased Donor Kidney TransplantationImmunosuppression In Kidney TransplantationMaintenance ImmunosuppressionTransplant PharmacologyTransplant RejectionCost Center AnalysisMycophenolate PharmacokineticsMycophenolate-based ImmunosuppressionMycophenolate-based RegimensRenal Transplant Care

References

3

MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTS

H. W. SOLLINGER · Transplantation · 1995 · 1.4K citations

Life Sciences, Nephrology, Pharmacotherapy +17

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group · Transplantation · 1996 · 1.1K citations

Medicine, Immunology, Nephrology +17

The cost effectiveness of mycophenolate mofetil in the first year after primary cadaveric transplant. U.S. Renal Transplant Mycophenolate Mofetil Study Group.

Sean D. Sullivan, Louis P. Garrison, Jennie H. Best · Journal of the American Society of Nephrology · 1997 · 55 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15